Phase IB-II clinical trial of melatonin oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing chemoradiation.

Trial Profile

Phase IB-II clinical trial of melatonin oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing chemoradiation.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 07 Mar 2018

At a glance

  • Drugs Melatonin (Primary)
  • Indications Mucositis
  • Focus First in man; Therapeutic Use
  • Acronyms MUCOMEL
  • Sponsors Spherium Biomed
  • Most Recent Events

    • 01 Mar 2018 Status changed from active, no longer recruiting to completed.
    • 13 Jan 2018 This trial was completed in Spain, according to European Clinical Trials Database
    • 05 Sep 2017 Planned End Date changed from 1 Mar 2018 to 1 May 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top